- According to the World Heart Federation, cardiovascular disease (CVD) is the leading cause of death in the Middle East and North Africa. It is estimated that 1.4 million people die each year from cardiovascular disease in the region, with total deaths from CVD increasing by 48% over the last 30 years.1
- On the occasion of World Heart Day, Cinfa Group seeks to highlight its commitment to cardiovascular health and its work to provide effective solutions in the fight against cardiovascular diseases, with a focus on patient care.
- Cinfa will be participating in the 35th Annual Congress of the Saudi Heart Association, from October 10th to 12th, as part of its effort to support cardiovascular health and with the aim of joining forces with the entire health industry and professionals.
Middle East: On the occasion of World Heart Day, Cinfa Group has pointed out the importance of maintaining a healthy lifestyle to reduce the rise of non-communicable diseases. The company is committed and works tirelessly to offer solutions for cardiovascular diseases (CVD), one of its main therapeutic areas.
Cardiovascular disease is the leading cause of death worldwide. Conditions affecting the heart or blood vessels, such as heart attack, stroke, and heart failure, cause more than 1.4 million deaths annually in Middle East and North Africa.
Dr. Alicia López de Ocáriz, Corporate Medical Director at Cinfa Group: “Our challenge is to continue offering patients medicines that help in the treatment and prevention of cardiovascular diseases. That is why we continue to develop medicines in this area”.
She also has highlighted that “everything we do for these patients to improve their cardiac function will enhance their quality of life and reduce the number of hospitalizations”.
Cinfa offers a wide range of products that address several diseases such as hypercholesterolemia, hypertension and heart failure, as well as its contribution in the prevention of cardiovascular diseases.
Taking advantage of World Heart Day, Cinfa aims to raise awareness about the prevention of cardiovascular diseases, as 80% of these conditions are preventable. Additionally, the company will contribute its expertise and join forces in the fight against these diseases by participating in the 35th Annual Congress of the Saudi Heart Association (SHA2024), taking place from October 10th to 12th.
**Please note, Thumbay Group, Gulf Medical University, and HEALTH magazine are not liable nor responsible for the facts, figures, and overall content of the press releases on our portal.
